2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Ovarian Q & A: Does Cediranib Have a Future In Ovarian Cancer? What Are the Preferred PARP Inhibitors and Is There Concern of AML/MDS?

227 views
July 29, 2020
Comments 0
Login to view comments. Click here to Login